Naveris Inc.

Naveris Inc. is a molecular diagnostics company developing and commercializing novel blood and saliva tests to enhance the early detection and clinical management of viral-associated cancers. Use routine NavDx® testing from Naveris® for a more complete picture of a patient’s HPV-positive cancer status than imaging scans alone by tracking changes in tumor tissue modified viral (TTMV®)-HPV DNA. More at NavDx.com